Just an update - I've withdrawn from the Apremilast trial. At week 24, my doctor requested of Celgene (the manufacturer) that they allow me to add Methotrexate to my protocol and do combo therapy. Many of her other patients in the trial are doing combo therapy with Methotrexate and are doing very well (they started the trial already on MTX).
Celgene denied the request, so I withdrew. Am glad I documented and photo-documented my time on the trial, as I never would have remembered the exact size of my plaques. Having the photos, taken at intervals, was key to really looking at efficacy of the drug. Unfortunately, from a skin perspective, I ended the trial significantly worse than how I began. Plaques were 2-3x larger, plaques had merged with other plaques (that were not there at the start of the trial) and my joints were about the same - maybe a slight improvement.
I wish I had been on MTX from the start (but had gone off of it months before due to pneumonia) - or that Celgene had approved my request to add it - but that did not happen. I know that many of my doctor's patients are having great success with the drug. Unfortunately, I was not one of those patients.
Julie